BRIEF published on 09/23/2025 at 21:45, 1 year 1 month ago Integrated BioPharma Reports Fiscal Year 2025 Results Financial Results Revenue Growth Net Income Operating Income Contract Manufacturing
PRESS RELEASE published on 09/23/2025 at 21:40, 1 year 1 month ago Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 Integrated BioPharma, Inc. reports 11.8% increase in revenue for Q2 2025. Operating income rises in Q2 & FY 2025. Net loss in Q2 but net income grows for FY 2025 Revenue Increase Net Income Net Loss Operating Income Integrated BioPharma
BRIEF published on 05/14/2025 at 21:35, 1 year 5 months ago Integrated BioPharma, Inc. publie ses résultats financiers pour le premier trimestre 2025 Résultats Financiers Croissance Des Revenus Résultat D'exploitation T1 2025 Principaux Clients
BRIEF published on 05/14/2025 at 21:35, 1 year 5 months ago Integrated BioPharma, Inc. Posts Financial Results for Q1 2025 Financial Results Revenue Growth Operating Income Q1 2025 Key Customers
PRESS RELEASE published on 05/14/2025 at 21:30, 1 year 5 months ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 Integrated BioPharma, Inc. reports a 6.1% revenue increase for Q1 2025 compared to Q1 2024. Company had operating income and net income growth. Key focus on core business and expanding customer base Financial Results Revenue Increase Net Income Operating Income Integrated BioPharma
BRIEF published on 02/13/2025 at 22:00, 1 year 8 months ago Integrated BioPharma publie ses résultats trimestriels avec un chiffre d'affaires en hausse Croissance Des Revenus Résultat D'exploitation Biopharmacie Intégrée Élargissement De La Clientèle Résultats Du 4e Trimestre
BRIEF published on 02/13/2025 at 22:00, 1 year 8 months ago Integrated BioPharma Reports Quarterly Results with Increased Revenue Revenue Growth Q4 Results Operating Income Customer Base Expansion Integrated BioPharma
PRESS RELEASE published on 02/13/2025 at 21:55, 1 year 8 months ago Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 Integrated BioPharma, Inc. reports 9.6% increase in revenue to $12.6 million for quarter ended Dec 31, 2024. Operating income of $0.2 million. Detailed financial results provided Financial Results Revenue Increase Quarterly Report Operating Income Integrated BioPharma
BRIEF published on 11/13/2024 at 23:38, 1 year 11 months ago Integrated BioPharma, Inc. annonce ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Revenu Net Résultats Du 3ème Trimestre 2024 Biopharmacie Intégrée Diversification De La Clientèle
BRIEF published on 11/13/2024 at 23:38, 1 year 11 months ago Integrated BioPharma, Inc. Announces Q3 2024 Financial Results Revenue Growth Net Income Integrated BioPharma Customer Diversification Q3 2024 Results
Published on 10/30/2026 at 12:20, 2 hours 5 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 2 hours 25 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/29/2026 at 22:01, 16 hours 24 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 16 hours 55 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/30/2026 at 13:50, 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/30/2026 at 13:48, 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 10/30/2026 at 12:00, 2 hours 25 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 10/30/2026 at 12:00, 2 hours 25 minutes ago Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:00, 6 hours 25 minutes ago Neoen secures AUD 1.8 billion in debt financing to support renewable energy portfolio in Australia
